TG Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference
23 September 2021 - 9:30PM
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael
S. Weiss, the Company’s Chairman and Chief Executive Officer, will
participate in a fireside chat during the 2021 Cantor Virtual
Healthcare Conference, taking place September 27 – 30, 2021. The
fireside chat is scheduled to take place on Monday, September 27,
2021 at 10:40 AM ET.
A live webcast of this presentation will be
available on the Events page, located within the Investors &
Media section, of the Company’s website at
http://ir.tgtherapeutics.com/events. A replay of the webcast will
be available on TG’s website following the event. ABOUT TG
THERAPEUTICS, INC.TG Therapeutics is a
fully-integrated, commercial stage biopharmaceutical company
focused on the acquisition, development and commercialization of
novel treatments for B-cell malignancies and autoimmune diseases.
In addition to an active research pipeline including five
investigational medicines across these therapeutic areas, TG has
received accelerated approval from the U.S. FDA for
UKONIQ® (umbralisib), for the treatment of adult patients with
relapsed/refractory marginal zone lymphoma who have received at
least one prior anti-CD20-based regimen and relapsed/refractory
follicular lymphoma who have received at least three prior lines of
systemic therapies. Currently, the Company has three programs in
Phase 3 development for the treatment of patients with relapsing
forms of multiple sclerosis (RMS) and patients with chronic
lymphocytic leukemia (CLL) and several investigational medicines in
Phase 1 clinical development. For more information,
visit www.tgtherapeutics.com, and follow us on
Twitter @TGTherapeutics and Linkedin.UKONIQ® is a
registered trademark of TG Therapeutics, Inc.
CONTACT: |
|
|
Investor Relations |
|
Email: ir@tgtxinc.com |
|
Telephone: 1.877.575.TGTX (8489), Option 4 |
|
|
|
Media Relations: |
|
Email: media@tgtxinc.com |
|
Telephone: 1.877.575.TGTX (8489), Option 6 |
TG Therapeutics (NASDAQ:TGTX)
Historical Stock Chart
From Apr 2024 to May 2024
TG Therapeutics (NASDAQ:TGTX)
Historical Stock Chart
From May 2023 to May 2024